Hypergrowth Screen

REGIME GREEN 2026-11-07 universe 5491 · scored 500 · v3 EDGAR-primary
13
Strong
163
Watchlist
24
New today
25
Dropped
10
High headroom
74/100
Data coverage

Action shortlist — strong & high 10–20x headroom (≤$30B)

#TickerNormStages G·E·P·T·V·BHeadroomMCapfwdPEG*Earnings
1
ETON
Eton Pharmaceuticals, Inc.
 91/100
+6.4
HIGH $1.6B 0.3 cheap —
2
KNSA
Kiniksa Pharmaceuticals Interna
 89/100
＝
HIGH $8.0B 0.9 cheap —
3
GKOS
Glaukos Corporation
 88/100
+0.1
HIGH $13.3B 1.3 reasonable, info —
4
ARXYOUNG
Accelerant Holdings
 83/83
-0.5
HIGH $3.3B 4.2 expensive, info Nov 12 5d
5
XMTR
Xometry, Inc.
 82/100
+0.1
HIGH $5.3B 1.4 reasonable, info —
6
HHH
Howard Hughes Holdings Inc.
 81/95
+0.8
HIGH $4.6B n/m —
7
HTFLYOUNG
Heartflow, Inc.
 76/86
+0.4
HIGH $4.6B n/m Nov 13 6d
8
TENNEWYOUNG
Tsakos Energy Navigation Ltd
 76/100
● new
HIGH $1.4B n/m Nov 19 12d
9
IOVA
Iovance Biotherapeutics, Inc.
 75/86
+1.4
HIGH $3.6B n/m —
10
SEZL
Sezzle Inc.
 72/92
+1.3
HIGH $5.0B 0.6 cheap —
Stage bar: G Growth /30 E Estimates /24 P Profitability /14 T Technicals /19 V Volume /5 B Balance /8 — hover any segment for its score

All 13 strong candidates (norm ≥ 70 + growth & estimate minimums)

#TickerNormStages G·E·P·T·V·BHeadroomMCapfwdPEG*Earnings
1
ETON
Eton Pharmaceuticals, Inc.
 91/100
+6.4
HIGH $1.6B 0.3 cheap —
2
KNSA
Kiniksa Pharmaceuticals Interna
 89/100
＝
HIGH $8.0B 0.9 cheap —
3
GKOS
Glaukos Corporation
 88/100
+0.1
HIGH $13.3B 1.3 reasonable, info —
4
ARXYOUNG
Accelerant Holdings
 83/83
-0.5
HIGH $3.3B 4.2 expensive, info Nov 12 5d
5
XMTR
Xometry, Inc.
 82/100
+0.1
HIGH $5.3B 1.4 reasonable, info —
6
HHH
Howard Hughes Holdings Inc.
 81/95
+0.8
HIGH $4.6B n/m —
7
REGN
Regeneron Pharmaceuticals, Inc.
 80/100
+2.1
MEDIUM $85.0B 3.0 expensive, info Jan 28 82d
8
HTFLYOUNG
Heartflow, Inc.
 76/86
+0.4
HIGH $4.6B n/m Nov 13 6d
9
TENNEWYOUNG
Tsakos Energy Navigation Ltd
 76/100
● new
HIGH $1.4B n/m Nov 19 12d
10
IOVA
Iovance Biotherapeutics, Inc.
 75/86
+1.4
HIGH $3.6B n/m —
11
SEZL
Sezzle Inc.
 72/92
+1.3
HIGH $5.0B 0.6 cheap —
12
BLLNYOUNG
BillionToOne, Inc.
 72/95
+1.1
HIGH $1.3B n/m —
13
SNOW
Snowflake Inc.
 71/100
+0.2
MEDIUM $97.3B 2.5 expensive, info Dec 03 26d

Sector mix: Healthcare 7 · Financial Services 2 · Industrials 1 · Real Estate 1 · Energy 1

Watchlist — top 30 of 163

#TickerNormMCapEarningsWhat to watch
1
VCEL
Vericel Corporation
 82/100
+0.5
 $2.8B — Needs rev YoY ≥25% and Growth ≥18/30 — watch next earnings
2
UCYCL
Unity Software Inc.
 77/100
+1.2
 $22.7B — Cyclical recovery — needs TTM revenue >1.1x its prior 3y peak · Needs rev YoY ≥25% and Growth ≥18/30 — watch next earnings
3
AMPL
Amplitude, Inc.
 76/100
+0.1
 $2.2B — Needs rev YoY ≥25% and Growth ≥18/30 — watch next earnings
4
CDNARAN
CareDx, Inc.
 74/100
-0.1
 $4.1B — Extended >4x off its 52w low — wait for a multi-week base · Needs rev YoY ≥25% and Growth ≥18/30 — watch next earnings
5
FLYW
Flywire Corporation - Voting
 74/100
+5.7
 $2.6B — Needs rev YoY ≥25% and Growth ≥18/30 — watch next earnings
6
RBRK
Rubrik, Inc.
 74/100
-0.4
 $21.8B Dec 04 27d Needs rev YoY ≥25% and Growth ≥18/30 — watch next earnings
7
ROKU
Roku, Inc.
 72/100
-2.5
 $23.7B — Needs rev YoY ≥25% and Growth ≥18/30 — watch next earnings
8
JANNEWYOUNG
Janus Living, Inc.
 72/91
● new
 $7.2B — Needs analyst confirmation — watch for upward EPS revisions · Young listing — durability guard cannot run yet
9
AXGNNEW
AxoGen, Inc.
 71/100
● new
 $3.0B — Needs rev YoY ≥25% and Growth ≥18/30 — watch next earnings
10
VRNS
Varonis Systems, Inc.
 71/100
+0.4
 $5.6B — Needs rev YoY ≥25% and Growth ≥18/30 — watch next earnings
11
LIONNEW
Lionsgate Studios Corp
 70/92
● new
 $4.2B Feb 05 90d Needs rev YoY ≥25% and Growth ≥18/30 — watch next earnings
12
IMAXCYCL
Imax Corporation
 69/100
+1.9
 $2.6B — Cyclical recovery — needs TTM revenue >1.1x its prior 3y peak
13
RXO
RXO, Inc.
 69/100
-0.7
 $4.6B — 1 pts from STRONG; weakest: Profitability 4/14
14
KDP
Keurig Dr Pepper Inc.
 69/100
-0.1
 $49.8B — 1 pts from STRONG; weakest: Estimates 6/24
15
LTC
LTC Properties, Inc.
 69/81
-0.3
 $2.5B — 1 pts from STRONG; weakest: Estimates 0/5
16
LFST
LifeStance Health Group, Inc.
 68/100
+0.2
 $5.3B — 2 pts from STRONG; weakest: Volume 0/5
17
AAMI
Acadian Asset Management Inc.
 68/92
+0.1
 $3.2B — 2 pts from STRONG; weakest: Volume 0/5
18
IOT
Samsara Inc.
 68/100
-0.3
 $24.2B Dec 04 27d 2 pts from STRONG; weakest: Volume 0/5
19
XERS
Xeris Biopharma Holdings, Inc.
 68/86
+0.6
 $2.8B — 2 pts from STRONG; weakest: Balance 0/8
20
INTA
Intapp, Inc.
 68/100
-0.1
 $3.4B — 2 pts from STRONG; weakest: Growth 10/30
21
HALO
Halozyme Therapeutics, Inc.
 68/100
-4.3
 $11.8B — 2 pts from STRONG; weakest: Volume 2/5
22
LOAR
Loar Holdings Inc.
 68/100
+0.3
 $7.1B — 2 pts from STRONG; weakest: Balance 4/8
23
WK
Workiva Inc.
 67/100
-0.9
 $4.1B — 3 pts from STRONG; weakest: Growth 9/30
24
AVPT
AvePoint, Inc.
 67/100
＝
 $3.5B — 3 pts from STRONG; weakest: Volume 0/5
25
AGYS
Agilysys, Inc.
 67/100
-0.1
 $3.4B Jan 26 80d 3 pts from STRONG; weakest: Growth 12/30
26
APPN
Appian Corporation
 65/100
-0.4
 $3.7B — 5 pts from STRONG; weakest: Growth 8/30
27
ELF
e.l.f. Beauty, Inc.
 65/100
-0.4
 $6.9B Feb 04 89d 5 pts from STRONG; weakest: Balance 2/8
28
ETSYCYCL
Etsy, Inc.
 65/100
-0.2
 $7.8B — Cyclical recovery — needs TTM revenue >1.1x its prior 3y peak
29
SMA
SmartStop Self Storage REIT, In
 65/95
+0.5
 $2.2B — 5 pts from STRONG; weakest: Balance 0/3
30
PLMR
Palomar Holdings, Inc.
 65/88
+0.5
 $4.1B — 5 pts from STRONG; weakest: Profitability 1/5

Dropped since last run

ARQT (STRONG CANDIDATE @ 76), CERT (WATCHLIST @ 55), CNO (WATCHLIST @ 66), DBX (WATCHLIST @ 59), DSGX (WATCHLIST @ 56), DXCM (WATCHLIST @ 59), ELV (WATCHLIST @ 55), EXPD (WATCHLIST @ 68), FIVN (WATCHLIST @ 58), FTDR (WATCHLIST @ 60), HOG (WATCHLIST @ 60), ISRG (WATCHLIST @ 59), LIVN (WATCHLIST @ 55), LYFT (WATCHLIST @ 58), MSI (WATCHLIST @ 55), MTD (WATCHLIST @ 60), NTAP (WATCHLIST @ 70), P (STRONG CANDIDATE @ 74), PANW (WATCHLIST @ 59), QLYS (WATCHLIST @ 60)

Deterministic output of run_screen_v3.py — the dashboard renders scores, it never changes them. Norm = points earned / points available; missing data is shown, not guessed. *fwdPEG is informational only. Backtest-validated methodology (9/9 winners, 1 false positive — Method tab). Do-not-advise list applied before screening. Data: SEC EDGAR & Yahoo Finance. Not financial advice — hypergrowth carries severe drawdown risk.